To Sustain Innovation, Randomized Controlled Trials Must Be Simplified

Randomized controlled trials must be simplified to sustain innovation in cardiovascular diseases, which are still the biggest killer in Europe, according to the Cardiovascular Round Table (CRT), an independent forum established by the European Society of Cardiology and comprised of cardiologists and representatives of the pharmaceutical, device and equipment industries.  The paper outlines barriers to investing in cardiovascular research and the authors recommend new ways to conduct clinical research to make investment more attractive and bring drugs to market sooner. read more

Read the whole article on

More from